Selecta Biosciences Inc. | Ownership
Companies that own Selecta Biosciences Inc.
OrbiMed Advisors LLC
1,842,797
8.23%
0
0.26%
06/30/2018
BlackRock Fund Advisors
794,024
3.55%
221,236
0%
06/30/2018
Silver Rock Financial LP
787,000
3.51%
41,925
3.19%
06/30/2018
The Vanguard Group, Inc.
615,276
2.75%
43,845
0%
06/30/2018
Kennedy Capital Management, Inc.
546,879
2.44%
456,627
0.13%
06/30/2018
Invus Public Equities Advisors LLC
500,000
2.23%
375,000
0.23%
06/30/2018
JPMorgan Investment Management, Inc.
436,746
1.95%
-21,975
0%
06/30/2018
Fidelity Management & Research Co.
279,423
1.25%
-139,556
0%
06/30/2018
T. Rowe Price Associates, Inc.
238,660
1.07%
214
0%
06/30/2018
Wasatch Advisors, Inc.
235,625
1.05%
19,803
0.02%
06/30/2018
| Address |
480 Arsenal Way
Watertown Massachusetts 02472
United States
|
|
Employees
|
- |
| Website |
http://www.selectabio.com |
| Updated |
07/08/2019 |
| Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies. |
